Pharmafile Logo

Neovoca Ltd

Neovoca Ltd is a consultancy founded on the belief that the patient is the first customer, and that the goals of industry, healthcare professionals and society, all meet with the aim of improved patient care. To consistently achieve this requires a legitimate and valuable dialogue between the healthcare industry and the consumer. Our Mission, is to help build those conversations by working across the public and private sectors, and our services are centred on helping the pharmaceutical industry achieve a stronger and considered conversation with those consumers who should be benefiting from years of painstaking and rigorous research.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Havas Life London

We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by strategically aligning promotion, medical education and PR across the product…

View Profile

MDNT

MDNT is a native Digital and Omnichannel agency focused solely on the healthcare, pharma, and life science industries. We’re highly experienced, no nonesense, and very good at what we do.

View Profile

Onyx Health

Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national and international reach. As we understand the healthcare market and…

View Profile

OPEN Health

OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health outcomes and patient wellbeing.

View Profile

Sciterion

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make a positive contribution to patient care. Real world experience of…

View Profile

Company Details

The Counting House, Tring, HP23 5TE, United Kingdom
07786 126686

 Latest Content from PMHub 

Extraordinary lives: advancing change in rare diseases

Rare Disease Day is all about raising awareness and generating change for the 300 million people worldwide living with a rare disease. On this day across the globe, the rare...

Extraordinary lives: advancing change in rare diseases

We are extending the conversation for Rare Disease Day by continuing to raise awareness and generate change for the 300 million people worldwide living with a rare disease, their families...

Stand-out Marketing: How to Stay One Step Ahead in Pharma

What do you need to do in order to stand out from the crowd in Pharma marketing? (Article written February 26th 2022)

Improving healthcare for rare disease patients

Following on from Rare Disease Day 2022, we decided to take a deeper look into the patient journey of those living with a rare health condition. In this blog, we...

Gamifying Remote Patient Monitoring

Dr. Emilia Molimpakis, CEO & Co-founder of Thymia, shares how their platform uses video games based on neuropsychology, alongside analyses of facial microexpressions and speech, to quickly, accurately, and objectively...

Fishawack Health expands its value, evidence, and market access capabilities with the acquisition of HEOR consultancy Policy Analysis Inc. (PAI)

Press Releases | March 3, 2022 | Avalere Health

Fishawack Health announces its expanded global Value, Evidence, and Access (VEA) capability for biopharmaceutical and medical technology companies, with a suite of end-to-end services spanning product lifecycle, coupled with unsurpassed...

Onyx Health Announces a “Double Hatrick” of New Appointments

Press Releases | March 3, 2022 | Onyx Health

Onyx Health continues to expand with six new appointments to its creative and communication teams, due to increased growth in its international client portfolio work.

Utilising Patient Insight in Pharma Marketing

The importance in understanding the patients view point when marketing in Pharma (Article written August 30th 2021)

Office move signals new era for Berkshire agency

Dice Medical Communications moves office due to business growth